Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POM PROM: Pitocin vs Oral Misoprostol for PROM IOL
NCT04028765Phase 4Completed
- Sponsor
- University of Pennsylvania
- Start
- Aug 2019
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of misoprostol in premature rupture of membranes (PROM), sponsored by University of Pennsylvania. Primary endpoint: Time From Induction of Labor (IOL) to Delivery. Started Aug 2019; status: completed.
02
Drugs
misoprostol
03
Conditions
premature rupture of membranes (PROM)
Beyond the preview
Go deeper on NCT04028765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04028765.